Go to Page # Page of 90

Vestibular Schwannoma: Pathogenesis and Treatment Development

 D. Bradley Welling, MD, PhD
Description: Drug development for treatment of Vestibular Schwannomas (VS) based upon improved understanding of the growth pathways which lead to targeted pharmacologic intervention. Summarize stereotactic radiation data in the treatment of VS and includes Case studies.
Views: 2965
Domain: Medical
Category: Therapy
Vestibular Schwannoma Update 2009: Pathogenesis and Treatment Development
Fitz-Hugh Symposium June 12 , 2009
D. Bradley Welling, MD, PhD The Ohio State University

Financial disclosure
� I have no financial interest to disclose � Off label drugs will be discussed but not recommended for treatment

Drug development for treatment of VS based upon improved understandin ... See more

Recent Presentations

Innovation in Allergy Immunotherapy

ASIT biotech treatments consist of a mixture of purified peptides from different selected sizes, produced from natural sources of allergens for allergy immunotherapy.

26 June, 2019
Bionure Farma
25 June, 2019
24 June, 2019